Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2137
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
WS04 - IASLC/IMIG Workshop - The Future of Mesothelioma Treatment
- 08:00 - 11:00
- 8/06/2022
- Location: Lehar 4
- Not for CME Credit
- Type: Workshop
- Track: N/A
- Moderators:Kenneth John O'Byrne, Arnaud Scherpereel
-
+
WS04.13 - Panel - Everything You Wanted to Know About Mesothelioma but Were Afraid to Ask
11:00 - 11:00 | Presenter: Patrick M Forde
- Abstract
Loading...
-
+
MA03 - Predicting Outcomes in Patients with Early Disease NSCLC
- 12:00 - 13:00
- 8/07/2022
- Location: Hall C8
- Not for CME Credit
- Type: Mini Oral
- Track: Early Stage Non-small Cell Lung Cancer
- Moderators:Terufumi Kato, Devayani Niyogi
-
+
MA03.04 - An Integrated Deep Learning Method to Predict Lung Cancer Recurrence Risk for Resected Stage IA NSCLC
12:07 - 12:12 | Presenter: Peng Huang
- Abstract
Loading...
-
+
LA01 - Lectureship Awards - Sunday (Live Streamed Session)
- 13:15 - 14:15
- 8/07/2022
- Location: Hall C1
- Not for CME Credit
- Type: Awards
- Track: N/A
- Moderators:Keunchil Park, Paul Bunn
-
+
LA01.05 - Daniel C. Ihde Lectureship Award for Medical Oncology
13:47 - 14:02 | Presenter: Patrick M Forde
- Abstract
Loading...
-
+
EP02.04 - Early Stage Non-small Cell Lung Cancer - Systemic Therapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Early Stage Non-small Cell Lung Cancer - Systemic Therapy
-
+
EP02.04-007 - Phase 2 Trial of Neoadjuvant KRASG12C Directed Therapy with Adagrasib (MRTX849) With or Without Nivolumab in Resectable NSCLC (Neo-KAN)
Presenter: Patrick M Forde- Abstract
Loading...
-
+
EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
-
+
EP08.01-086 - Pooled Mutant KRAS-Targeted Peptide Vaccine with Nivolumab and Ipilimumab in Advanced KRAS Mutated Non-Small Cell Lung Cancer
Presenter: Samuel Rosner- Abstract
Loading...
-
+
OA15 - Patient Selection in Advanced NSCLC Immunotherapy
- 14:30 - 15:30
- 8/09/2022
- Location: Hall C7
- Not for CME Credit
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Moderators:Pilar Garrido, António Araújo
-
+
OA15.05 - HUDSON: An Open-Label, Multi-Drug, Biomarker-Directed Phase 2 Study in NSCLC Patients Who Progressed on Anti-PD-(L)1 Therapy
14:52 - 15:02 | Presenter: Benjamin Besse
- Abstract
Loading...
